United Therapeutics Corporation 13D and 13G filings for TOTTENHAM ACQUISITION I LTDUNI:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-02 06:02 am Unchanged |
2022-12-31 | 13G | TOTTENHAM ACQUISITION I LTDUNI TOTAU |
UNITED THERAPEUTICS Corp UTHR |
2,869,517 3.890% |
0 (Unchanged) |
Filing |
| 2023-01-17 06:02 am Sale |
2022-12-31 | 13G | TOTTENHAM ACQUISITION I LTDUNI TOTAU |
UNITED THERAPEUTICS Corp UTHR |
2,869,517 3.890% |
-786,575 (-21.51%) |
Filing |
| 2022-01-14 4:30 pm Sale |
2021-12-31 | 13G | TOTTENHAM ACQUISITION I LTDUNI TOTAU |
UNITED THERAPEUTICS Corp UTHR |
3,656,092 5.880% |
-512,722 (-12.30%) |
Filing |
| 2021-01-08 4:30 pm Purchase |
2020-12-30 | 13G | TOTTENHAM ACQUISITION I LTDUNI TOTAU |
UNITED THERAPEUTICS Corp UTHR |
4,168,814 7.000% |
4,168,814 (New Position) |
Filing |